EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Treatments for Diabetic Macular Edema

Tomoaki Tatsumi iD

International Journal of Molecular Sciences · 31.05.2023 · 24 (11) · 9591

DOI: 10.3390/ijms24119591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.05.2023. Verfasst von Tomoaki Tatsumi. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Diabetes Mellitus. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy is a major retinal disorder and a leading cause of blindness. Diabetic macular edema (DME) is an ocular complication in patients with diabetes, and it can impair vision significantly. DME is a disorder of the neurovascular system, and it causes obstructions of the retinal capillaries, damage of the blood vessels, and hyperpermeability due to the expression and action of vascular endothelial growth factor (VEGF). These changes result in hemorrhages and leakages of the serous components of blood that result in failures of the neurovascular units (NVUs). Persistent edema of the retina around the macula causes damage to the neural cells that constitute the NVUs resulting in diabetic neuropathy of the retina and a reduction in vision quality. The macular edema and NVU disorders can be monitored by optical coherence tomography (OCT). Neuronal cell death and axonal degeneration are irreversible, and their development can result in permanent visual loss. Treating the edema before these changes are detected in the OCT images is necessary for neuroprotection and maintenance of good vision. This review describes the effective treatments for the macular edema that are therefore neuroprotective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyDiabetes MellitusHumansVascular Endothelial Growth Factor ARetinaTomography, Optical CoherenceEdemaAngiogenesis Inhibitors

Stichwörter der Autor:innen

anti-vascular endothelial growth factordiabetic macular edemadiabetic neuropathydiabetic retinopathyretinal neurovascular unit

Substanzen

Vascular Endothelial Growth Factor AAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan.

ORCID-Profile: Tomoaki Tatsumi

Zitieren

APA

Tatsumi, T. (2023). Current Treatments for Diabetic Macular Edema. International Journal of Molecular Sciences, 24(11), 9591. https://doi.org/10.3390/ijms24119591

Vancouver

Tatsumi T. Current Treatments for Diabetic Macular Edema. International Journal of Molecular Sciences. 2023;24(11):9591. doi:10.3390/ijms24119591

BibTeX
@article{Tatsumi2023,
  author = {Tatsumi, Tomoaki},
  title = {Current Treatments for Diabetic Macular Edema},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {9591},
  doi = {10.3390/ijms24119591}
}
Kostenlos starten →